Who we are

AplusA (with US affiliate AplusA Bell Falla) is one of the world’s leading independent market research companies dedicated to healthcare.

Thanks to the excellence and commitment of our teams, our challenge for globalization has been well and truly met: more than half of our turnover is generated overseas, two-thirds of our services are international (conducted in 75 countries), and our teams are a true reflection of our business: multi-nationals. We are now, globally, among the Top 10 Global Healthcare Market Research Companies, and the Top 3 Independent Players. The acquisition of IFOP and Sociovision and their inclusion into the AplusA-IFOP group have even increased our capabilities to develop innovative solutions based on advanced techniques used outside the Health industry.

The current ongoing convergence between Healthcare and Information Technology opens up a wonderful horizon of new opportunities: in this context, our aim is to continue to provide our clients with the best tools to support their actions, to inform their decisions, to validate their strategic options.

Strengthened by our expertise, our stable and committed shareholder base is there to support our strong growth. Our ambition is to build an exquisite enterprise, of great worth and shared values.

We will achieve this by acquiring new skills and attracting new talents, developing new products and solutions, establishing partnerships, furthering our business models and advancing our associates.

For the men and women of AplusA, those who are with us today, as well as those who will be joining us tomorrow, we will provide a safe space to foster their talents and creativity. Such is the condition and the measure of our success.

Pierre PIGEON,
President

Who we are

AplusA (with US affiliate AplusA Bell Falla) is one of the world’s leading independent market research companies dedicated to healthcare.

Thanks to the excellence and commitment of our teams, our challenge for globalization has been well and truly met: more than half of our turnover is generated overseas, two-thirds of our services are international (conducted in 75 countries), and our teams are a true reflection of our business: multi-nationals. We are now, globally, among the Top 10 Global Healthcare Market Research Companies, and the Top 3 Independent Players. The acquisition of IFOP and Sociovision and their inclusion into the AplusA-IFOP group have even increased our capabilities to develop innovative solutions based on advanced techniques used outside the Health industry.

The current ongoing convergence between Healthcare and Information Technology opens up a wonderful horizon of new opportunities: in this context, our aim is to continue to provide our clients with the best tools to support their actions, to inform their decisions, to validate their strategic options.

Strengthened by our expertise, our stable and committed shareholder base is there to support our strong growth. Our ambition is to build an exquisite enterprise, of great worth and shared values.

We will achieve this by acquiring new skills and attracting new talents, developing new products and solutions, establishing partnerships, furthering our business models and advancing our associates.

For the men and women of AplusA, those who are with us today, as well as those who will be joining us tomorrow, we will provide a safe space to foster their talents and creativity. Such is the condition and the measure of our success.

Pierre PIGEON,
President

 

Our added values

When discussing AplusA, our clients often underscore our expertise and our eagerness to explore untapped healthcare markets. Our work rests on the following pillars: 

  •  Total commitment

Your satisfaction is our ultimate goal. Our clients trust us to deliver, and we work relentlessly and transparently to do so. To us, the destination is as important as the journey. 

  • True experts  

We are passionate about working in partnership with our clients through dedicating our advanced research skills and medical expertise to uncover the right solutions, swiftly and efficiently, to help you stand out in a highly competitive environment. 

  • A desire to explore

We explore new horizons, face new challenges and anticipate the unexpected. Our expertise continues to grow as it perpetually seeks innovation and ventures into the unknown.

Commitment from true experts with a desire to explore

INNOVATION: “Something different that has impact” Scott D. Anthony – HBR
Our history speaks for our capacity to think forward and welcome successful companies
into our organization to embrace impactful innovative solutions for our clients:

Areas of expertise

AplusA is founded and led by physicians, so clinical knowledge is at the core of everything we do. We have 30 years of experience in conducting healthcare market research studies across all major therapeutic areas, including rare diseases, that answer macro and micro market questions. Our highly experienced teams combine unparalleled healthcare market understanding with augmented solutions in order to deliver in-depth and actionable information to our clients.

Our expertise focuses on three main areas: unparalleled patient charts expertise, long-established performance trackers, and an ever-evolving range of syndicated solutions, augmented with insights from advanced analytics.

Therapeutic Areas

Aesthetic Medicine & Surgery
Anaesthesiology & Pain Management
Auto-Immune Diseases
Biosimilars & Generics
Blood
Cardiovascular Diseases
Central Nervous System
Coagulation
Dermatology
Diabetes
Digestive Disorders
Ear Nose Throat and Dental
Gynecology & Fertility
Infectious Diseases
Kidney Diseases
Metabolic Disorders
Musculoskeletal Diseases
Nutrition
Oncology & Hemato-Oncology
Ophthalmology
Rare Diseases
Respiratory
Rheumatology
Urology
Vaccines
Virology

Medical Devices

Administration devices
Other medical equipment
Surgical instruments
Laser
Reconstitution devices
Band aid
Contact lens
Dental equipment
Prothesis & implants
Stimulators (Brain, Heart, Neurology)
Colostomy Bags

Diagnostics

Blood (and other fluid) tests
Diagnostic devices
Imaging (and other exploratory techniques)
Genetic Tests
Anatomic and Cytologic

Market Research Targets

Physicians
Patients
Caregivers
Pharmacists
Nurses
Payors
KOLs

Digital Health

Electronic Health Records / Electronic Medical Records
mHealth
Health Apps
Telehealth
Diagnostic / Monitoring Devices
Pain Management Devices
Rehabilitation Devices
Respiratory Therapy Devices

AplusA’s organization mirrors our client’s organization and reflects our ambition to guide and monitor the healthcare industry transformation

International market research
Market research in France
Market reseach in Germany

International and US market research

International NIS
(observational studies)

Supplier for market research
agencies and for consultant firms

Our organization, balanced between the US and EU, with a completely integrated management, matches our client’s organization and ensures senior attention and consistency across regions

APLUSA teams

Core management team

Pierre founded AplusA, formerly ISIS Research in 1989. Pierre is President and Shareholder of AplusA and Shareholder and President of the IFOP supervisory board. He is a qualified MD specializing in Endocrinology and Nutritional and Metabolic disorders.

 

 

Pierre Pigeon, MD
President
Founder, AplusA

Christine joined AplusA in 1990 and supports the senior business directors to develop client relationships worldwide. She is responsible for identifying new partnerships and developing innovative solutions for AplusA clients. Christine is a qualified MD specializing in palliative care and holds an MBA in Pharmaceutical Marketing.

Christine Maï, MD
EVP, Chief Sales & Marketing Officer

To begin his career, he joined Arthur Andersen’s Lyon office as a financial auditor in 1994. Since 2002, he has been holding CFO positions in various businesses such as water coolers services, electric motors industry and engineering and consulting services. Nicolas has a strong experience in organization, finance and LBOs. He joined AplusA in 2016 and is member of the Executive Committee. Nicolas graduated with a master’s degree in management from EDHEC Business School in Lille, France.

 

 

 

Nicolas Ciampi
Chief Financial Officer

After a 20 year successful career in various human resources positions, Sophie Benes joins AplusA as our Human Resources Director. She provides our team with a French American experience gained in different Silicon Valley start-ups and other HighTec and industrial companies in Rhône-Alpes.
She is in charge of developing and implementing talent management through individual and collective coaching in our multi-cultural and multi-national environment.

Sophie Benes
Human Resources Director

Pierre Pigeon, MD
President
Founder, AplusA

Pierre founded AplusA, formerly ISIS Research in 1989. Pierre is President and Shareholder of AplusA and Shareholder and President of the IFOP supervisory board. He is a qualified MD specializing in Endocrinology and Nutritional and Metabolic disorders.

 

 

Christine Maï, MD
EVP, Chief Sales & Marketing Officer

Christine joined AplusA in 1990 and supports the senior business directors to develop client relationships worldwide. She is responsible for identifying new partnerships and developing innovative solutions for AplusA clients. Christine is a qualified MD specializing in palliative care and holds an MBA in Pharmaceutical Marketing.

Nicolas Ciampi
Chief Financial Officer

To begin his career, he joined Arthur Andersen’s Lyon office as a financial auditor in 1994. Since 2002, he has been holding CFO positions in various businesses such as water coolers services, electric motors industry and engineering and consulting services. Nicolas has a strong experience in organization, finance and LBOs. He joined AplusA in 2016 and is member of the Executive Committee. Nicolas graduated with a master’s degree in management from EDHEC Business School in Lille, France.

Sophie Benes
Human Resources Director

After a 20 year successful career in various human resources positions, Sophie Benes joins AplusA as our Human Resources Director. She provides our team with a French American experience gained in different Silicon Valley start-ups and other HighTec and industrial companies in Rhône-Alpes.
She is in charge of developing and implementing talent management through individual and collective coaching in our multi-cultural and multi-national environment.

Site managers

Alain is a sociologist with over 30 years in healthcare research. Whilst successfully growing one of the top research agencies in France which became AplusA through a merger, he has also pioneered several techniques in patient and communication research in ethical and OTC healthcare. Alain was the first to impose the use of advanced analytical techniques based on semantics and psychology in Healthcare opinion research. Alain has four specific areas of expertise; sales forces, patient research, pharmacists and physicians. Alain supports his clients in understanding, motivating and increasing the impact of sales forces on product marketing. He also foresaw the increasing role of patients in prescribing and pioneered patient research methodologies including Patient Pathway and Euro Health Prism, a powerful patient segmentation technique. He successfully helps clients translate the emotional involvement of physicians into brand equity. He is currently developing an innovative service that determines the sources of customers’ purchasing decisions in pharmacies at national level.

Alain Collomb
Vice President, AplusA France

Kevin Kelly has nearly 20 years of business strategy and global insights experience within the healthcare and consumer package goods industries. Prior to joining AplusA Bell Falla in 2018, Kevin was part of the senior management team of several specialized marketing firms, including BuzzBack Market Research, HRA-Healthcare Research & Analytics, and RG+A. Kevin has specific expertise in the U.S. hospital and integrated healthcare systems market, helping clients to navigate the complex formulary and treatment protocol approval process within large healthcare systems. In addition to his health systems background, Kevin also has extensive experience in global patient treatment simulation and demand forecasting as well as a track record for innovation in online data collection and interviewing techniques. Kevin has been a frequent presenter at healthcare industry events and conferences and has been published in Quirk’s Marketing Research Review. He holds an MM degree from Rider University and an MS degree from The George Washington University.

Kevin Kelly
COO, AplusA Bell Falla US

Alain Collomb
Vice President, AplusA France

Alain is a sociologist with over 30 years in healthcare research. Whilst successfully growing one of the top research agencies in France which became A+A through a merger, he has also pioneered several techniques in patient and communication research in ethical and OTC healthcare. Alain was the first to impose the use of advanced analytical techniques based on semantics and psychology in Healthcare opinion research. Alain has four specific areas of expertise; sales forces, patient research, pharmacists and physicians. Alain supports his clients in understanding, motivating and increasing the impact of sales forces on product marketing. He also foresaw the increasing role of patients in prescribing and pioneered patient research methodologies including Patient Pathway and Euro Health Prism, a powerful patient segmentation technique. He successfully helps clients translate the emotional involvement of physicians into brand equity. He is currently developing an innovative service that determines the sources of customers’ purchasing decisions in pharmacies at national level.

Kevin Kelly
COO, AplusA Bell Falla US

Kevin Kelly has nearly 20 years of business strategy and global insights experience within the healthcare and consumer package goods industries. Prior to joining AplusA Bell Falla in 2018, Kevin was part of the senior management team of several specialized marketing firms, including BuzzBack Market Research, HRA-Healthcare Research & Analytics, and RG+A. Kevin has specific expertise in the U.S. hospital and integrated healthcare systems market, helping clients to navigate the complex formulary and treatment protocol approval process within large healthcare systems. In addition to his health systems background, Kevin also has extensive experience in global patient treatment simulation and demand forecasting as well as a track record for innovation in online data collection and interviewing techniques. Kevin has been a frequent presenter at healthcare industry events and conferences and has been published in Quirk’s Marketing Research Review. He holds an MM degree from Rider University and an MS degree from The George Washington University.

Business unit Directors

Before joining AplusA in 2017, Alexander held leading positions at Kantar Health and Ipsos Healthcare where he was responsible for multi-country market research studies in all phases of the product life cycle management. Prior to this, he worked for a pharmaceutical company (Pharmacia) with responsibilities for secondary and primary market research in different therapy areas. Alexander has more than 15 years of experience in healthcare market research. He holds a master’s degree in economics from the University of Konstanz (Germany)

Alexander Edte
International Business Unit Director

Having worked at AplusA for over 20 years, Alexandra has unique experience in prescription monitoring studies in multiple therapeutic areas and in all phases of product life-cycle management. She also has extensive experience in hospital markets and in a wide-range of diseases including, but not limited to, haematology, oncology, infectious diseases, biotherapies and metabolic disorders.
Alexandra has a masters in statistics and has been conducting full service market research for over 20 years including several years specializing in consumer research for Ipsos.

Alexandra Andreo
France Prescription Unit Director

Anna Robbertz has over 25 years of consulting and marketing research experience as well as another five years in pharmaceutical marketing on the client side. Anna has extensive experience across a range of therapeutic areas. Anna has expertise in both qualitative and quantitative marketing research. She is best known for qualitative research and is highly-sought as a moderator. Anna’s research skills include in-depth, one-on-one interviewing and focus group moderation for a range of stakeholders, including HCPs, KOLs, patients, sales reps, and payers. Anna’s skills touch on all areas of qualitative research, including discussion guide development, interviewing, data analysis, report writing, and presentation of findings. She has extensive experience in managing global qualitative projects. Anna has an MBA in Marketing from Bentley College, and a B.S. in Public Health from the University of Massachusetts at Amherst. Anna is a native of the Netherlands.

Anna Robbertz
US Business Unit Director

Graduated as a pharmacist at Paris-Sud University, Arnaud Raphael serves as a Business Director for French domestic studies.
With experience on both client and agency sides, Arnaud has a particular expertise in Product positioning and Product launch monitoring in most therapeutic areas. He has has now particular interest in Biotech products.

Arnaud Raphael, PharmD
France Business Unit Director

Béatrice Du Sordet co-founded AplusA and currently supports clients as an International Business Unit Director. She conducts projects in more than 75 countries and leads large strategic performance trackers across multiple therapeutic areas.

Beatrice du Sordet
International Business Unit Director

 Cécile has over 20 years experience in healthcare market research. She joined AplusA in 2000 and is now a Business Unit Director. She has worked across multiple therapeutics areas with a unique expertise in oncology and hematology. Cécile is particularly interested in hospital research. Cécile is a graduate of pharmacology and bio-molecular sciences.

Cecile Rousseau
France Business Unit Director

Charles has spent over 20 years working in pharmaceutical market research having worked both on the Client and Agency sides. Prior to joining AplusA, he was Divisional Director at GfK Healthcare for 3 years. Before that, he was head of international market research at Novo Nordisk, covering: Diabetes, Haemophilia, Growth Hormone and Women’s health. Charles has experience of working in both qualitative and quantitative research covering all aspects of research techniques from conventional to advanced and has worked in most therapy areas including, Diabetes, Cardiovascular, Oncology, Metabolic, Respiratory, CNS, Diabetes, Endocrine, Women’s health, Skin, ENT, infectious diseases. Charles is Managing Director of the AplusA London office.

Charles
International Business Unit Director

After spending several years in South Africa and Italy, Izabel joined AplusA with 20 years experience in the healthcare sector. She has worked on both client (Product Range Manager and Marketing Director) and agency sides of the industry always maintaining an international outlook. Her research background includes survey design and execution, strategy planning and consulting. Izabel seeks innovative solutions to asses emotional and rational choice drivers. Izabel is graduated with honors as a Doctor of Pharmacy and holds an MBA.

Izabel Freret, PharmD
International Business Unit Director

Jim Goldenberg has hands-on experience both as a seasoned marketing consultant and marketing manager.
His industry experience includes marketing management at Best Foods, American Home Products, and Lehn & Fink where he led marketing activities for well-known CPG brands such as Chef-Boyardee, Jiffy Pop, Old London, Lysol, and many others.
Jim began his career in pharmaceutical market research with Migliara Kaplan the leader in pharma market research, where he developed and managed internet capabilities in a wide range of therapeutic categories.
Additionally, Jim led internet research and client development at V2 Gfk, and TNS, gaining broad experience in a variety of therapy areas most notably, Pain, Oncology, Diabetes, CNS (Parkinsons, MS, Alzheimers, ADHD), and Gastrointestinal.
Jim has over twenty-five years of pharmaceutical market research experience. He holds a BA in Marketing from Fairleigh Dickinson University.

Jim Goldenberg
US Business Unit Director

After first working in consumer research, Magali joined AplusA in 2002 and specializes in patient chart studies covering all stages of the product lifecycle.
Through her expertise in a wide range of disease areas (hematology, oncology, infectious diseases, dermatology, CNS). Magali graduated in Psychology and holds a Master’s degree in Market Research, Marketing and Communication (Sciences Po Grenoble).

Magali Marion
France Prescription Unit Manager

Specializing in French domestic market research studies, Marie-Christine Ducrot serves as a Business Unit Director. She has a particular interest in market research involving psychological aspects of physicians’ decisions including relationships between patients/physicians and physicians/pharma companies as well as the evolution of the role of HCPs and the global impact. Marie Christine holds a DEA in Experimental and Social Psychology

Marie Christine Ducrot
France Business Unit Director

Nadège joined AplusA in 2020 to develop market research in OTC products. With a strong background in market research and product management, Nadège started her career agency side as a quantitative market research executive before working client side in OTC products for a pharmaceutical company. Her roles have included Data Research Executive, then International Product Manager and Head of Market Research and Data Panels. Nadège is a marketing graduate (Toulouse Business School).

Nadège Meillier
International Business Unit Director

Rose-Marie Carneiro is a Business Unit Director with more than 20 years’ experience in pharmaceutical market research in both France and Australia.
As an expert in both qualitative and quantitative market research techniques, Rose-Marie pays special attention to patients and consumers in different therapeutic areas such as CV, respiratory, CNS, diabetes, aesthetics and cosmetics, women’s health, baby nutrition, senior nutrition, pain management and wellbeing. On top of this, her finesse extends to different aspects of the healthcare provider/consumer relationship including, but not limited to, health management, compliance, reactions to promotional activties and the buying process of over the counter products.

Rose-Marie Carneiro
Business Unit Director
Patient Research

Sigi started his career 1989 at Novartis pharma where he worked in different functions of market research on national and European level. This included covering a wide range of aspects related to quantitative and qualitative market research, analytics, strategic planning and forecasting. Later he joined TNS/Kantar Health, working on mainly large scale international quantitative studies. He gained a deep understanding of qualitative projects during his first years in London. Over the years, Sigi worked on multiple therapy areas and brands, ranging from CV/CNS to immunology, oncology, rare diseases and biosimilars.
Sigi joined AplusA in 2019 after contracting roles for BMS and GSK. He is based in the London office of AplusA.

Siegfried Ertl
International Business Unit Director

Steve is a statistician and consultant specializing in pharmaceutical markets and quantitative marketing research methods. He has applied his statistical and software development background to create several original quantitative methods tailored to the needs of pharmaceutical marketers. Steve was an Assistant Professor of Marketing at New York University. He taught courses on marketing strategy in the undergraduate, MBA, and Executive Education programs. Steve led all advanced quantitative marketing research projects and is one of the senior methodologists at AABF. Steve has an MBA and Ph.D. from Columbia University. He has published articles in medical journals and in academic marketing journals. (List of publications and presentations available on request.) Steve has also given presentations at the PMRG Research Institute, AMA Advanced Research Techniques (ART) Forum, and the Sawtooth Software Conference. (List of publications and posters available on request.) Steve is a hands-on project manager who loves innovative methodologies as well as the nuts-and-bolts of marketing research production and reporting.

Steve Bell
US Business Unit Director
Chief Methodologist

Alexander Edte
International Business Unit Director

Before joining A+A in 2017, Alexander held leading positions at Kantar Health and Ipsos Healthcare where he was responsible for multi-country market research studies in all phases of the product life cycle management. Prior to this, he worked for a pharmaceutical company (Pharmacia) with responsibilities for secondary and primary market research in different therapy areas. Alexander has more than 15 years of experience in healthcare market research. He holds a master’s degree in economics from the University of Konstanz (Germany)

Alexandra Andreo
France Prescription Unit Director

Having worked at AplusA for over 20 years, Alexandra has unique experience in prescription monitoring studies in multiple therapeutic areas and in all phases of product life-cycle management. She also has extensive experience in hospital markets and in a wide-range of diseases including, but not limited to, haematology, oncology, infectious diseases, biotherapies and metabolic disorders.
Alexandra has a masters in statistics and has been conducting full service market research for over 20 years including several years specializing in consumer research for Ipsos.

Anna Robbertz
US Business Unit Director

Anna Robbertz has over 25 years of consulting and marketing research experience as well as another five years in pharmaceutical marketing on the client side. Anna has extensive experience across a range of therapeutic areas. Anna has expertise in both qualitative and quantitative marketing research. She is best known for qualitative research and is highly-sought as a moderator. Anna’s research skills include in-depth, one-on-one interviewing and focus group moderation for a range of stakeholders, including HCPs, KOLs, patients, sales reps, and payers. Anna’s skills touch on all areas of qualitative research, including discussion guide development, interviewing, data analysis, report writing, and presentation of findings. She has extensive experience in managing global qualitative projects. Anna has an MBA in Marketing from Bentley College, and a B.S. in Public Health from the University of Massachusetts at Amherst. Anna is a native of the Netherlands.

Arnaud Raphael, PharmD
France Business Unit Director

Graduated as a Pharmacist at Paris-Sud University, Arnaud Raphael serves as a Business Director for French domestic studies.
With experience on both client and agency sides, Arnaud has a particular expertise in Product positioning and Product launch monitoring in most therapeutic areas. He has has now particular interest in Biotech products.

Beatrice du Sordet
International Business Unit Director

Béatrice Du Sordet co-founded AplusA and currently supports clients as an International Business Unit Director. She conducts projects in more than 75 countries and leads large strategic performance trackers across multiple therapeutic areas.

Cecile Rousseau
France Business Unit Director

 Cécile has over 20 years experience in healthcare market research. She joined AplusA in 2000 and is now a Business Unit Director. She has worked across multiple therapeutics areas with a unique expertise in oncology and hematology. Cécile is particularly interested in hospital research. Cécile is a graduate of pharmacology and bio-molecular sciences.

Charles
International Business Unit Director

Charles has spent over 20 years working in pharmaceutical market research having worked both on the Client and Agency sides. Prior to joining AplusA, he was Divisional Director at GfK Healthcare for 3 years. Before that, he was head of international market research at Novo Nordisk, covering: Diabetes, Haemophilia, Growth Hormone and Women’s health. Charles has experience of working in both qualitative and quantitative research covering all aspects of research techniques from conventional to advanced and has worked in most therapy areas including, Diabetes, Cardiovascular, Oncology, Metabolic, Respiratory, CNS, Diabetes, Endocrine, Women’s health, Skin, ENT, infectious diseases. Charles is Managing Director of the AplusA London office.

Izabel Freret, PharmD
International Business Unit Director

 After spending several years in South Africa and Italy, Izabel joined AplusA with 20 years experience in the healthcare sector. She has worked on both client (Product Range Manager and Marketing Director) and agency sides of the industry always maintaining an international outlook. Her research background includes survey design and execution, strategy planning and consulting. Izabel seeks innovative solutions to asses emotional and rational choice drivers. Izabel is graduated with honors as a Doctor of Pharmacy and holds an MBA.

Jim Goldenberg
US Business Unit Director

Jim Goldenberg has hands-on experience both as a seasoned marketing consultant and marketing manager.
His industry experience includes marketing management at Best Foods, American Home Products, and Lehn & Fink where he led marketing activities for well-known CPG brands such as Chef-Boyardee, Jiffy Pop, Old London, Lysol, and many others.
Jim began his career in pharmaceutical market research with Migliara Kaplan the leader in pharma market research, where he developed and managed internet capabilities in a wide range of therapeutic categories.
Additionally, Jim led internet research and client development at V2 Gfk, and TNS, gaining broad experience in a variety of therapy areas most notably, Pain, Oncology, Diabetes, CNS (Parkinsons, MS, Alzheimers, ADHD), and Gastrointestinal.
Jim has over twenty-five years of pharmaceutical market research experience. He holds a BA in Marketing from Fairleigh Dickinson University.

Magali Marion
France Prescription Unit Manager

After first working in consumer research, Magali joined AplusA in 2002 and specializes in patient chart studies covering all stages of the product lifecycle.
Through her expertise in a wide range of disease areas (hematology, oncology, infectious diseases, dermatology, CNS). Magali graduated in Psychology and holds a Master’s degree in Market Research, Marketing and Communication (Sciences Po Grenoble).

Marie Christine Ducrot
France Business Unit Director

Specializing in French domestic market research studies, Marie-Christine Ducrot serves as a Business Unit Director. She has a particular interest in market research involving psychological aspects of physicians’ decisions including relationships between patients/physicians and physicians/pharma companies as well as the evolution of the role of HCPs and the global impact. Marie Christine holds a DEA in Experimental and Social Psychology

Nadège Meillier
International Business Unit Director

Nadège joined AplusA in 2020 to develop market research in OTC products. With a strong background in market research and product management, Nadège started her career agency side as a quantitative market research executive before working client side in OTC products for a pharmaceutical company. Her roles have included Data Research Executive, then International Product Manager and Head of Market Research and Data Panels. Nadège is a marketing graduate (Toulouse Business School).

Rose-Marie Carneiro
International Business Unit Director

Rose-Marie Carneiro is a Business Unit Director with more than 20 years’ experience in pharmaceutical market research in both France and Australia.
As an expert in both qualitative and quantitative market research techniques, Rose-Marie pays special attention to patients and consumers in different therapeutic areas such as CV, respiratory, CNS, diabetes, aesthetics and cosmetics, women’s health, baby nutrition, senior nutrition, pain management and wellbeing. On top of this, her finesse extends to different aspects of the healthcare provider/consumer relationship including, but not limited to, health management, compliance, reactions to promotional activties and the buying process of over the counter products.

Siegfried Ertl
International Business Unit Director

Sigi started his career 1989 at Novartis pharma where he worked in different functions of market research on national and European level. This included covering a wide range of aspects related to quantitative and qualitative market research, analytics, strategic planning and forecasting. Later he joined TNS/Kantar Health, working on mainly large scale international quantitative studies. He gained a deep understanding of qualitative projects during his first years in London. Over the years, Sigi worked on multiple therapy areas and brands, ranging from CV/CNS to immunology, oncology, rare diseases and biosimilars.
Sigi joined AplusA in 2019 after contracting roles for BMS and GSK. He is based in the London office of AplusA.

Steve Bell
US Business Unit Director
Chief Methodologist

Steve is a statistician and consultant specializing in pharmaceutical markets and quantitative marketing research methods. He has applied his statistical and software development background to create several original quantitative methods tailored to the needs of pharmaceutical marketers. Steve was an Assistant Professor of Marketing at New York University. He taught courses on marketing strategy in the undergraduate, MBA, and Executive Education programs. Steve led all advanced quantitative marketing research projects and is one of the senior methodologists at AABF. Steve has an MBA and Ph.D. from Columbia University. He has published articles in medical journals and in academic marketing journals. (List of publications and presentations available on request.) Steve has also given presentations at the PMRG Research Institute, AMA Advanced Research Techniques (ART) Forum, and the Sawtooth Software Conference. (List of publications and posters available on request.) Steve is a hands-on project manager who loves innovative methodologies as well as the nuts-and-bolts of marketing research production and reporting.

Quality and Compliance

We comply with industry best practices and recognize the importance of a stringent but fluid compliance to international and local regulations. Our process is continuously adjusted according to the most up-to-date legal and ethical requirements; and staff members receive the necessary training under the supervision of the quality management team.

Quality

Process, Training, Control

– Quality Department
– AplusA’s Standard process
– Quality Management System
– Client Satisfaction
– Continuous improvement

Pharmacovigilance

Adverse Event Reporting

– AplusA’s AER process frequently updated
– 100% internal staff training
– 100% fieldwork partners training

Safety

Data protection, Data preservation

– Secured access to data
– Confidentiality clause
– Business continuity plan
– Backup and restore process

COMPLIANCE

Code of Conduct, Respondent rights, Anti-bribery

– US & French Sunshine Act (loi Bertrand)
– GDPR and CNIL
– Institutional review board (IRB)
and ethics committee submission
– ESOMAR
– EphMRA
– Intellus
– BVM
– BHBIA
– MRS
– ASOCS
– ISPOR

Let’s talk!

Want to find out more information about AplusA?
Whether you would like to discuss a specific project or hear more about our services and expertise – we’d be delighted to hear from you.